Calcium Glycerophosphate Market Analysis by Product Type (Oral Calcium Products, Oral Care, and Pharmaceutical Grade); and by Application (Pharmaceutical, and Food & Beverage) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Buy Now Report ID: 917 | Published Date: Feb 09, 2023
The global calcium glycerophosphate market is expected to generate revenue of ~USD 101.2 Million by the end of 2033 by growing at a CAGR ~4% over the forecast period, i.e., 2023 – 2033. Further, the market generated revenue of ~USD 65.7 Million in the year 2022. The growth of the market can be attributed primarily to the widespread consumption of soft drinks and beverages containing low pH levels which requires a higher amount of glycerophosphate to remove harmful properties from the liquid. For instance, a wide range of ready-to-drink (RTD) products, such as Cold Brew Coffee (which has a pH level of 5), have grown by 20% in 2017 and by 2022, the growth is expected to increase to 68% of all such products introduced.
Get more information on this report:Request Sample PDF
Calcium glycerophosphate is a fine and white powder composed of calcium salts of glycerophosphoric acid. In addition to serving as a protective agent against tooth decay, it is also used to neutralize acidic foods after being consumed. Furthermore, the increasing expenditure on consumer products coupled with the rise in per capita income is expected to fuel the global calcium glycerophosphate market growth during the forecast period. It was observed that, in January 2022, spending on consumer goods in the United States increased from approximately 7.5, compared to a decline of around 6.5% in December 2021.
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~4% |
|
Base Year Market Size (2022) |
~ USD 65.7 Million |
|
Forecast Year Market Size (2033) |
~ USD 101.2 Million |
|
Regional Scope |
|
Growth Drivers
Growing Demand for Dietary Supplements Among People- In a survey in 2019, it was found that nearly 75% of American adults take dietary supplements on a daily basis. This included approximately 80% of female adults and 75% of male adults.
In addition, the rising awareness about health concerns, coupled with the growing demand for dietary supplements, is anticipated to enlarge the global calcium glycerophosphate market size over the forecast period. Calcium glycerophosphate is used as an active compound in calcium glycerylphosphate. Taking it in the form of supplements or as a dietary mineral component, it helps in maintaining the level of calcium in bodies. It improves bone mineral density and treats calcium deficiency.
Increasing Exports of Dentifrices Including Toothpowder and Toothpaste- According to the statistics by the International Trade Center (Trademap), the value of exports of Dentifrices in China in the year 2021 was recorded to be USD 453,125 thousand, which was an increase from USD 414,924 thousand in the previous year.
Product Approval by Government Organization Such as FDA (Food and Drug Administration)- In accordance with FDA standards, calcium glycerophosphate is approved as a generally recognized safe (GRAS) food ingredient for use as a nutrient supplement, a source of calcium or phosphorus, as well as an ingredient used in food products such as gelatin, ice cream, and sauces.
Prevalence of Heartburn and Gastroesophageal Reflux Disease (GERD) Among Individuals- Calcium glycerophosphate is widely used in medicines to treat heartburn, irritable bowel syndrome, and other gastroesophageal problems. It was observed that Gastroesophageal reflux disease (GERD) is one of the most prevalent digestive disorders in the United States with a prevalence of about 22%.
Growing Periodontal Disease Incidence Among Individuals- According to the Centers for Disease Control and Prevention, 47.2% of adults aged 30 and over are affected by some form of periodontal disease. 70.1% of people aged over 65 years are suffering from this disease.
Availability of Alternatives of Calcium Glycerophosphate
High Production Costs Associated with the Product
Concern about Side Effects Due to Excessive Intake of Calcium Glycerophosphate
People might hesitate to consume
The global calcium glycerophosphate market is segmented and analyzed for demand and supply by application into pharmaceutical, and food & beverage. Among these segments, the pharmaceutical segment captured the largest market share by 66% in the year 2022 backed by the extensive use of calcium glycerophosphate in the manufacturing of pharmaceutical medications such as treating IBS, heartburn, and gastrointestinal problems. Furthermore, the increasing exports of oral and dental hygiene products and production in pharma industries are expected to drive segment growth over the forecast period. Statistics provided by the International Trade Center (Trademap) indicate that in 2021, the global export value of oral and dental hygiene products in the United States was USD 1,872,494 thousand, an increase of USD 1,651,373 thousand from the previous year.
The Asia Pacific calcium glycerophosphate market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of market can be ascribed to the growing awareness among the population of the importance of dental cleanliness and general oral health coupled with an increase in dental care visits is expected to drive the regional market growth during the forecast period. Furthermore, the adoption of innovative dental care products and rising disposable income are projected to drive calcium glycerophosphate market growth in Asia Pacific during the forecast period.
Our in-depth analysis of the global calcium glycerophosphate market includes the following segments:
|
By Product Type |
|
|
By Application |
|
Global Calcium PVT. LTD.
Isaltis Inc. announced that it Macco Organiques Canada, which specializes in mineral salts for the food and pharmaceutical markets, with calcium and magnesium chlorides of pharmaceutical grade as its main products has taken control of Isaltis to create a global leader in high purity mineral salts.
Seppic SA has entered into a partnership agreement with Bioactor B.V. This strategic agreement will not only expand the portfolio of Seppic Inc., but also address major trends in the dietary supplements sector, such as beauty, vitality, mood, memory, sport nutrition, bone and gut health.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Smruti Ranjan, Rajrani Baghel
Ans: Growing demand for dietary supplements among people are estimated to majorly boost the market growth.
Ans: The market is anticipated to attain CAGR of ~4% over the forecast period, i.e., 2023 – 2033.
Ans: Availability of alternatives of calcium glycerophosphate is estimated to challenge the market growth.
Ans: The market in Asia Pacific region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
Ans: The major players in the market are Sri Vyjayanthi Labs Pvt. Ltd., Penta Manufacturing Company, LLC., Seppic SA, NITIKA CHEMICALS PHARMACEUTICAL SPECIALITIES PVT. LTD., Anmol Chemicals Group, Chempol, American Elements, Isaltis Inc., and others.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue-generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by product type, application, and by region.
Ans: The pharmaceutical segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
